A year into funding cuts, where do NIH researchers stand?

“We’re not signaling to this next generation of early-career researchers that there is a stable, predictable opportunity for careers in science that are based on government funding,” Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, told Healthcare Brew. “Talent follows stability.”

Healthcare Brew - April 22, 2026

Previous
Previous

American dream must move fast to keep up with the times, says former CEO of the ACS

Next
Next

Two oncology powerhouses are integrating to accelerate cancer vaccine research